ALCAM and systemic lupus erythematosus: Elevated urinary levels of ALCAM demonstrated a good ability in discriminating patients with LN from non-renal SLE or inactive SLE (AUC 0.75–0.96, Sn 60–94%, Sp 53.3–100%, PPV 86–98%, NPV 65.5–92%) and healthy controls (AUC 0.82–0.98) [115,141,150,151,152,153].